Methanex (NASDAQ:MEOH - Get Free Report) TSE: MX had its target price raised by Royal Bank Of Canada from $65.00 to $70.00 in a note issued to investors on Friday,Benzinga reports. The firm presently has a "sector perform" rating on the specialty chemicals company's stock. Royal Bank Of Canada's target price points to a potential upside of 9.99% from the company's previous close.
A number of other research firms have also recently weighed in on MEOH. Raymond James Financial upped their price target on Methanex from $52.00 to $65.00 and gave the stock a "market perform" rating in a report on Thursday, April 16th. UBS Group upped their price target on Methanex from $60.00 to $70.00 and gave the stock a "buy" rating in a report on Thursday, April 9th. BMO Capital Markets upped their price target on Methanex from $65.00 to $70.00 and gave the stock an "outperform" rating in a report on Wednesday, March 18th. Zacks Research upgraded Methanex from a "strong sell" rating to a "hold" rating in a report on Tuesday, April 14th. Finally, Jefferies Financial Group increased their target price on Methanex from $50.00 to $60.00 and gave the company a "buy" rating in a research note on Wednesday, March 11th. One equities research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $62.40.
Check Out Our Latest Report on MEOH
Methanex Trading Down 2.9%
Shares of NASDAQ:MEOH traded down $1.90 during trading on Friday, reaching $63.64. 535,262 shares of the stock were exchanged, compared to its average volume of 1,273,124. The company has a debt-to-equity ratio of 0.99, a quick ratio of 1.37 and a current ratio of 2.06. Methanex has a 12-month low of $31.57 and a 12-month high of $66.75. The firm has a market cap of $4.92 billion, a price-to-earnings ratio of -129.58 and a beta of 0.56. The firm's 50-day moving average price is $56.48 and its 200 day moving average price is $46.29.
Methanex (NASDAQ:MEOH - Get Free Report) TSE: MX last issued its earnings results on Wednesday, April 29th. The specialty chemicals company reported $0.30 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.42 by ($0.12). The firm had revenue of $957.42 million for the quarter, compared to analysts' expectations of $964.76 million. Methanex had a positive return on equity of 2.92% and a negative net margin of 1.25%.The firm's revenue for the quarter was up 8.7% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.30 EPS. On average, sell-side analysts anticipate that Methanex will post 5.96 earnings per share for the current fiscal year.
Hedge Funds Weigh In On Methanex
Several institutional investors and hedge funds have recently made changes to their positions in MEOH. Amundi boosted its stake in shares of Methanex by 3.9% during the 1st quarter. Amundi now owns 22,791 shares of the specialty chemicals company's stock valued at $800,000 after buying an additional 848 shares during the last quarter. Hsbc Holdings PLC acquired a new stake in shares of Methanex during the 2nd quarter valued at approximately $419,000. Invesco Ltd. raised its position in shares of Methanex by 15.7% during the 2nd quarter. Invesco Ltd. now owns 249,231 shares of the specialty chemicals company's stock valued at $8,250,000 after acquiring an additional 33,827 shares in the last quarter. AXA S.A. acquired a new stake in shares of Methanex during the 2nd quarter valued at approximately $166,000. Finally, Qube Research & Technologies Ltd raised its position in shares of Methanex by 327.0% during the 2nd quarter. Qube Research & Technologies Ltd now owns 47,284 shares of the specialty chemicals company's stock valued at $1,565,000 after acquiring an additional 36,211 shares in the last quarter. 73.49% of the stock is currently owned by hedge funds and other institutional investors.
Key Methanex News
Here are the key news stories impacting Methanex this week:
- Positive Sentiment: Board, auditor and executive pay were supported by shareholders at the April 30 AGM, removing near‑term governance uncertainty. Methanex Shareholders Back Board, Auditor and Pay at April 30 AGM
- Positive Sentiment: The board declared a quarterly cash dividend of US$0.185/share (payable June 30), which supports income investors and provides a baseline of shareholder return. Methanex Corporation – Notice of Cash Dividend
- Neutral Sentiment: JPMorgan reaffirmed a Neutral rating but raised its price target to $65 from $56 — a modest upside to current levels but no change to conviction. Benzinga: JPMorgan rating
- Neutral Sentiment: Management reported adjusted EBITDA of $220M and adjusted net income of $23M and described the company as “well‑positioned,” signaling operational resilience despite the headline miss. Methanex Reports First Quarter 2026 Results
- Negative Sentiment: Q1 EPS of $0.30 missed consensus (~$0.42–$0.47) and revenue of ~$957M slightly trailed estimates; EPS fell sharply vs. $1.30 a year ago — a primary driver of the share decline. Zacks: Methanex Q1 Earnings Lag Estimates
- Negative Sentiment: The company recorded a small net loss attributable to mark‑to‑market share‑based compensation (linked to the share price increase), producing a negative net margin and raising short‑term earnings volatility concerns. Methanex Q1 2026 Results
Methanex Company Profile
(
Get Free Report)
Methanex Corporation is a Vancouver, Canada–based company and one of the world's largest producers and suppliers of methanol. The company manufactures methanol, a key feedstock for a wide range of chemical products and industrial applications. Methanex markets its product to customers in energy, plastics, paints and coatings, and various chemical sectors, positioning the company as a critical link in the global supply chain for basic chemicals.
The company's core product, methanol, serves as a building block for downstream chemicals such as formaldehyde, acetic acid and methyl tertiary butyl ether (MTBE).
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Methanex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Methanex wasn't on the list.
While Methanex currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.